Charlotte Harrison
@charlotteh560.bsky.social
📤 24
đź“Ą 38
đź“ť 3
Freelance science writer and editor
Researchers are increasingly using organ chips and organoids alongside or instead of animals to model drug safety, biological mechanisms and rare diseases. My latest for Lab Animal
@natureportfolio.nature.com
rdcu.be/eH7Pj
With insight from
@nc3rs.bsky.social
@emulatebio.bsky.social
and others
loading . . .
New approach methodologies gain momentum, providing human-relevant alternatives to animal models
Lab Animal - Researchers are increasingly using organ-on-chips and organoids alongside or instead of animals to model drug safety, biological mechanisms and rare diseases.
https://rdcu.be/eH7Pj
1 day ago
0
0
1
Can amylin-based drugs upstage GLP-1 agonists? They could avoid muscle loss and gastrointestinal side effects of current obesity therapies. My latest for
@natbiotech.nature.com
rdcu.be/ezwbM
loading . . .
Can amylin-based drugs upstage GLP-1 agonists?
Nature Biotechnology - Analogs of the pancreatic peptide hormone amylin are making strides in obesity as developers zoom in on oral drugs that can emulate or even improve on injectable GLP-1...
https://rdcu.be/ezwbM
about 2 months ago
0
8
3
reposted by
Charlotte Harrison
Nature Biotechnology
4 months ago
Biopharma dives into tumor-seeking radioactive drugs
www.nature.com/articles/s41...
loading . . .
Biopharma dives into tumor-seeking radioactive drugs - Nature Biotechnology
Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy cancerous cells with minimum dama...
https://www.nature.com/articles/s41587-025-02681-1
0
4
2
Hello Bluesky! Let’s try a first post…here’s my latest story for
@naturebiotech.bsky.social
on
@vertexpharma.bsky.social
non-opioid pain killer and next-gen NaV1.8 inhibitors in the pipeline
rdcu.be/ealj0
loading . . .
Vertex’s opioid-free drug for acute pain wins FDA approval
Nature Biotechnology - Society, patients and clinicians welcome a much-needed non-opioid pain medication. Vertex’s first-in-class analgesic Journavx could soon be followed by a new generation...
https://rdcu.be/ealj0
7 months ago
0
3
4
you reached the end!!
feeds!
log in
